Atrás
Rango del Día
$5.47
$5.63
Rango de 52 Semanas
$3.81
$10.08
Volumen
1,602,310
Promedio 50D / 200D
$6.75
/
$6.88
Cierre Anterior
$5.44
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 1746.1 | 0.4 |
| P/B | 70.7 | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | 0.2 | 3.8 |
| Rev Growth 5Y % | 55.8 | 10.0 |
| D/E | 2.8 | 0.2 |
Puntos Clave
Revenue grew 55.75% annually over 5 years — strong growth
Debt/Equity of 2.76 — high leverage
Generating 27.93M in free cash flow
P/E of 1746.10 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 12.03%
Cash machine — converts 5041.52% of earnings into free cash flow
Crecimiento
Revenue Growth (5Y)
55.75%
Revenue (1Y)43.72%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
N/A
ROIC36.29%
Net Margin0.19%
Op. Margin8.53%
Seguridad
Debt / Equity
2.76
Current Ratio2.19
Interest Coverage0.86
Valoración
P/E Ratio
1746.10
P/B Ratio70.67
EV/EBITDA35.91
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 43.72% | Revenue Growth (3Y) | 33.43% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 55.75% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 291.85M | Net Income (TTM) | 554,000.0 |
| ROE | N/A | ROA | 0.14% |
| Gross Margin | 81.70% | Operating Margin | 8.53% |
| Net Margin | 0.19% | Free Cash Flow (TTM) | 27.93M |
| ROIC | 36.29% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2.76 | Current Ratio | 2.19 |
| Interest Coverage | 0.86 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 1746.10 | P/B Ratio | 70.67 |
| P/S Ratio | 3.31 | PEG Ratio | -22.52 |
| EV/EBITDA | 35.91 | Dividend Yield | 0.00% |
| Market Cap | 967.34M | Enterprise Value | 894.06M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 291.85M | 203.07M | 163.91M | 110.25M | 49.59M |
| Net Income | 554,000.0 | -54.84M | -62.26M | -94.66M | -122.73M |
| EPS (Diluted) | 0.00 | -0.37 | -0.45 | -0.70 | -1.55 |
| Gross Profit | 238.43M | 166.24M | 135.27M | 87.61M | 36.27M |
| Operating Income | 24.90M | -33.65M | -44.01M | -81.94M | -115.16M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 383.53M | 323.06M | 322.60M | 344.52M | 304.36M |
| Total Liabilities | 369.84M | 352.68M | 329.38M | 299.34M | 209.13M |
| Shareholders' Equity | 13.69M | -29.62M | -6.78M | 45.19M | 95.23M |
| Total Debt | 37.76M | 271.45M | 229.19M | 198.06M | 88.07M |
| Cash & Equivalents | 111.04M | 71.62M | 67.45M | 121.97M | 67.27M |
| Current Assets | 240.31M | 167.66M | 156.26M | 186.82M | 142.60M |
| Current Liabilities | 109.57M | 100.44M | 95.19M | 73.62M | 79.04M |